March 2017 P&T Updates

Similar documents
July 2017 P&T Updates

November 2018 P & T Updates

May 2017 P&T Updates

January 2018 P & T Updates

May 2016 P & T Updates

Partners Notice of Change March 2017

P&T Committee Meeting Minutes GHP Family March 21, 2017

Pegylated Interferons and Ribavirins

March 2018 P & T Updates

Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

Pegasys Hepatitis B. Pegasys (peginterferon alfa-2a) Description

2018 CareOregon Advantage Part D Formulary Changes

Appendix 2. Adjuvant Regimens. AC doxorubin 60 mg/m 2 every 3 weeks x 4 cycles Cyclophosphamide 600 mg/m 2

Clinical Policy: Ranolazine (Ranexa) Reference Number: CP.PMN.34 Effective Date: Last Review Date: 02.19

March 2017 Pharmacy & Therapeutics Committee Decisions

Prescription Drug Benefit Rider

Aetna Better Health. Specialty Drug Program

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)

Drug Class Prior Authorization Criteria Immune Globulins

Prescription Drug Benefit Rider V

Step Therapy Approval Criteria

See Important Reminder at the end of this policy for important regulatory and legal information.

Month/Year of Review: November 2014 Date of Last Review: June 2012 PDL Classes: Anti-anginals, Cardiovascular

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information.

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

Modular Program Report

Specialty Drug List - Sorted by Therapeutic Class Developed for the Mississippi Division of Medicaid by Mercer

Step Therapy Approval Criteria

See Important Reminder at the end of this policy for important regulatory and legal information.

Hepatitis B Prior Authorization Policy

Injectable Drugs Requiring Pre-Service Approval

**CRITERIA UNDER CMS REVIEW**

ANGINA PECTORIS. angina pectoris is a symptom of myocardial ischemia in the absence of infarction

Clinical Policy: Pemetrexed (Alimta) Reference Number: CP.PHAR.368 Effective Date: Last Review Date: Line of Business: Medicaid

2017 Formulary Addendum Notice of Change

Ontario Drug Benefit Formulary/Comparative Drug Index

HMO and PPO Updates September Commercial Results

Clinical Policy: Eltrombopag (Promacta) Reference Number: ERX.SPA.71 Effective Date:

Quarterly pharmacy formulary change notice

Drug Class Literature Scan: Antianginals

2017 Medicare Part D Formulary Change

Drug Class Monograph

Pharmacy Updates Summary

Just the Basics: Pharmacology for the EMT

See Important Reminder at the end of this policy for important regulatory and legal information.

Hepatocellular Carcinoma: Can We Slow the Rising Incidence?

Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

Evolving Uses of IVIG in myositis

2017 Formulary Addendum Notice of Change

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

Hepatitis B Virus. Taylor Page PharmD Candidate 2019 February 1, 2019

2017 Formulary Addendum Notice of Change

IMMUNE GLOBULIN (IVIG AND SCIG) Brand Name Generic Name Length of Authorization Bivigam IVIG Per Medical Guidelines Carimune IVIG Per Medical

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

Hepatitis B Treatment Pearls. Agenda

HMSA Pharmacy Newsletter April 2006 For Participating Medical Practitioners

Step Therapy Approval Criteria

Texas Prior Authorization Program Clinical Edit Criteria

Immunologic Products asdhealthcare.com

See Important Reminder at the end of this policy for important regulatory and legal information.

Primary Diagnosis: Diagnosis Code(s) (if known): Individual s Weight (lbs) (kg)

2017 Formulary Addendum Notice of Change (Prescription Drug Plans)

POLICIES AND PROCEDURE MANUAL

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES

Medical Therapies in Ovarian Cancer The Arabic Perspectives. Mezghani Bassem -Tunisia

Section I contains changes to the Highmark Select/Choice Formulary.

2017 Medicare Part D Formulary Change

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

BRINTELLIX. Step Therapy Criteria HealthTeam Advantage Formulary ID: Version 6 Effective Date: 1/1/2016. PRODUCT(s) AFFECTED BRINTELLIX

See Important Reminder at the end of this policy for important regulatory and legal information.

Regimens highlighted in red contain an expensive drug that is not currently publicly funded for the regimen and treatment intent.

Clinical Policy: Hepatitis B Drugs Reference Number: AZ.CP.PHAR.03 Effective Date: Last Review Date: Line of Business: Arizona Medicaid

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

Pharmacy and Medical Guideline Updates

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

Prior Authorization Program Information (Effective April 1st, 2018)

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

Intron A Hepatitis B. Intron A (interferon alfa-2b) Description

Chronic Hepatitis B Drug Therapies: Frequently Asked Questions

Emblem Medicaid 3Q18 Formulary Updates

HMSA Pharmacy Newsletter February

Look-Alike/Sound-Alike (LASA) Medication Chart

MedStar Medicare Choice Pharmacy Services

Ovarian Cancer Survival. Ovarian Cancer Follow-up. Ovarian Cancer Treatment. Management of Recurrent Ovarian Carcinoma. 15,520 cancer deaths

222 pain reliever from canada

Immune Globulins. Subcutaneous Immune Globulin: Cuvitru, Hizentra and HyQvia

Clinical Policy: Immune Globulins Reference Number: CP.PHAR.103 Effective Date: 08/12 Last Review Date: 09/17 Line of Business: Medicaid

Clinical Policy: Anakinra (Kineret) Reference Number: CP.PHAR.244 Effective Date: Last Review Date: Line of Business: HIM, Medicaid

Objectives: Describe poly-adp-ribose polymerase (PARP) inhibitors mechanism of action.

Transcription:

March 2017 P&T Updates Commercial Triple Tier 4th Tier Applicable Traditional Prior Auth DICLEGIS 3 No 2 No Yes EMVERM 2 No 2 Yes Yes Detailed s 4 tablets per day, 9 month supply per year Pinworms: 1 tablet Alternatives No nitroglycerin sublingual tablets, nitroglycerin transdermal nitroglycerin, Nitrostat, Nitro-Dur, Nitro-Bid LAMIVUDINE HBV 100 MG 2 No 2 No Yes 1 tablet per day PREZISTA 150 MG 2 No 2 No Yes 6 tablets per day PREZISTA 75 MG 2 No 2 No Yes 2 tablets per day RUBRACA 3 Yes 2 Yes Yes 4 tablets per day, 30 day supply per Lynparza* fill VEMLIDY 2 No 2 No Yes 1 tablet per day entecavir, adefovir, Intron-A, Pegasys, Epivir HBV (solution), Baraclude (solution), Viread No Yes Yes 1 tablet per day aspirin 81 mg, omeprazole,

CHIP Tier Prior Auth DICLEGIS 2 No Yes EMVERM 2 Yes Yes Detailed s 4 tablets per day, 9 month supply per year Pinworms: 1 tablet per fill tablets - Alternatives nitroglycerin sublingual tablets, nitroglycerin transdermal nitroglycerin, Nitrostat, Nitro-Dur, Nitro- Bid LAMIVUDINE HBV 100 MG 2 No Yes 1 tablet per day PREZISTA 150 MG 2 No Yes 6 tablets per day PREZISTA 75 MG 2 No Yes 2 tablets per day RUBRACA 2 Yes Yes 4 tablets per day, 30 day supply Lynparza* VEMLIDY 2 No Yes 1 tablet per day entecavir, adefovir, Intron- A, Pegasys, Epivir HBV (solution), Baraclude (solution), Viread aspirin 81 mg, omeprazole, - Yes Yes 1 tablet per day

GHP Family GHP Family Tier Prior Auth Detailed s Alternative(s) COLCHICINE 0.6 MG TABLET Generic No Yes 3 tablets daily allopurinol DICLEGIS TABLET Brand No Yes 4 tablets daily, 9 month duration DRYSOL SOLUTION Generic No No - DUTASTERIDE 0.5 MG CAPSULE Generic No No - finasteride EMVERM Brand Yes Yes Pinworms: 1 tablet nitroglycerin SL tabs, nitroglycerin SL spray, nitroglycerin ER caps, nitroglycerin transdermal patch LAMIVUDINE 100 MG TABLET Generic No Yes 1 tablet daily L-METHYLFOLATE 7.5 MG, 15 MG TABLET Generic No Yes 1 tablet daily folic acid PREZISTA 150 MG TABLET Brand No Yes 6 tablets daily PREZISTA 75 MG TABLETS Brand No Yes 2 tablets daily RUBRACA Brand Yes Yes 4 tablets daily Lynparza* VEMLIDY Brand No Yes one tablet daily Lamivudine HBV, Entecavir, Intron A, Pegasys, Baraclude, Viread^ Yes Yes one tablet daily omeprazole, aspirin 81 mg, aspirin 325 mg

Geisinger Gold $0 Deductible CUVITRU Specialty EMVERM Brand Preferred Standard Prior Auth Detailed s Yes - - Yes Yes 12 tablets in 30 days Alternative(s) Carimune*, Flebogamma*, Gammagard*, Gamunex*, Hizentra*, Hyqvia*, Octagam*, Privigen* - - - - - nitroglycerin SL tablets, nitroglycerin SL spray INFLECTRA Specialty Yes - - methotrexate, Enbrel*, Humira*, Remicade* RUBRACA Specialty VEMLIDY Brand Preferred Yes Yes 4 tablets/day No Yes 1 tablet/day Carboplatin, liposomal doxorubicin, paclitaxel, cisplatin, topotecan, docetaxel, gemcitabine, Avastin* lamivudine HBV, Viread, entecavir - - - - -

Marketplace Tier Prior Auth DICLEGIS 4 No Yes EMVERM 3 Yes Yes Detailed s 4 tablets per day, 9 month supply per year Pinworms: 1 tablet Alternatives nitroglycerin sublingual tablets, nitroglycerin transdermal nitroglycerin, Nitrostat, Nitro-Dur, Nitro-Bid LAMIVUDINE HBV 100 MG 3 No Yes 1 tablet per day PREZISTA 150 MG 3 No Yes 6 tablets per day PREZISTA 75 MG 3 No Yes 2 tablets per day RUBRACA 5 Yes Yes 4 tablets per day, 30 day supply Lynparza* VEMLIDY 3 No Yes 1 tablet per day entecavir, adefovir, Intron-A, Pegasys, Epivir HBV (solution), Baraclude (solution), Viread Yes Yes 1 tablet per day aspirin 81 mg, omeprazole,